1. Home
  2. NGVT vs AGIO Comparison

NGVT vs AGIO Comparison

Compare NGVT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • AGIO
  • Stock Information
  • Founded
  • NGVT 1964
  • AGIO 2007
  • Country
  • NGVT United States
  • AGIO United States
  • Employees
  • NGVT N/A
  • AGIO N/A
  • Industry
  • NGVT Major Chemicals
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGVT Industrials
  • AGIO Health Care
  • Exchange
  • NGVT Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • NGVT 2.1B
  • AGIO 2.4B
  • IPO Year
  • NGVT N/A
  • AGIO 2013
  • Fundamental
  • Price
  • NGVT $55.91
  • AGIO $43.21
  • Analyst Decision
  • NGVT Buy
  • AGIO Strong Buy
  • Analyst Count
  • NGVT 2
  • AGIO 4
  • Target Price
  • NGVT $58.00
  • AGIO $59.33
  • AVG Volume (30 Days)
  • NGVT 185.6K
  • AGIO 553.8K
  • Earning Date
  • NGVT 10-29-2025
  • AGIO 10-30-2025
  • Dividend Yield
  • NGVT N/A
  • AGIO N/A
  • EPS Growth
  • NGVT N/A
  • AGIO N/A
  • EPS
  • NGVT N/A
  • AGIO 11.13
  • Revenue
  • NGVT $1,324,800,000.00
  • AGIO $40,875,000.00
  • Revenue This Year
  • NGVT N/A
  • AGIO $23.76
  • Revenue Next Year
  • NGVT $2.69
  • AGIO $148.23
  • P/E Ratio
  • NGVT N/A
  • AGIO $3.86
  • Revenue Growth
  • NGVT N/A
  • AGIO 30.57
  • 52 Week Low
  • NGVT $28.49
  • AGIO $23.42
  • 52 Week High
  • NGVT $60.77
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 53.19
  • AGIO 66.64
  • Support Level
  • NGVT $53.81
  • AGIO $39.71
  • Resistance Level
  • NGVT $56.12
  • AGIO $43.69
  • Average True Range (ATR)
  • NGVT 1.64
  • AGIO 1.43
  • MACD
  • NGVT 0.15
  • AGIO 0.15
  • Stochastic Oscillator
  • NGVT 68.80
  • AGIO 89.02

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: